• Otilimab ELISA Kit
1 1

AntibodySystem

KDC06703

Otilimab ELISA Kit

Otilimab ELISA Kit

Title

Catalog No.: KDC06703

Catalog No. KDC06703
Product name Otilimab ELISA Kit
Size 96 T
Description PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human CSF2 has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Otilimab in the sample competitively binds to the pre-coated protein with biotin-labeled Otilimab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Otilimab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications Used for the quantitative determination of Otilimab concentration in serum and plasma.
Stability and Storage When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Detection method Colorimetric
Precision CV<20%
Sample type Plasma, Serum
Assay type Quantitative
Sensitivity 80.29 ng/mL
Range 125 - 8,000 ng/mL
Recovery 80-120%
Background Otilimab is an IgG1 mAb that binds to GM-CSF and hinders its interaction with GM-CSFRα; it was developed by Morphosys AG (MOR-103) and then sublicensed to GSK (GSK3196165) to conduct large-scale clinical trials.
Alternative Names MOR-04357, 3196165, GSK3196165, MOR103, CAS: 1638332-55-4
Shipping 2-8 ℃
Note For Research Use Only.
전체 세부 정보 보기